NEW YORK (GenomeWeb News) – OncoMethylome Sciences today reported fiscal 2008 revenue growth of 15 percent and a 2 percent increase in its net loss year over year.

The Liege, Belgium-based firm brought in total revenues of €3 million ($3.9 million) for 2008, up from revenues of €2.6 million for 2007. OncoMethylome said the increase was due to new products and collbaorations with pharmaceutical companies.

Its net loss for the year was €10.2 million, or €.77 per share, compared to a net loss of €10 million, or €.85 per share, for 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.